SureTrader SureTrader
Home > Boards > US Listed > Medical - Healthcare >

Acasti Pharma, Inc (ACST)

ACST RSS Feed
Add ACST Price Alert      Hide Sticky   Hide Intro
Moderator: ash111, I.B.Broke
Search This Board:
Last Post: 11/29/2016 5:16:13 PM - Followers: 42 - Board type: Free - Posts Today: 0

Acasti Pharma is a biopharmaceutical innovator advancing a potentially best-in-class cardiovascular drug, CaPre®, for the treatment of hypertriglyceridemia, a chronic condition affecting an estimated one-third of the U.S. population.

Established in August 2008, Acasti is focused on addressing an important market need for an effective, safe and well-absorbed omega-3 therapeutic that can address a patient’s lipid profile — making a positive impact on the major lipids associated with cardiovascular disease risk.


 
 


President and CEO 
Jan D'Alvise
LinkedIn



Acasti’s Phase 3-ready investigational candidate CaPre® will be the first pharmaceutical omega-3 product sourced from krill oil. CaPre® has successfully completed phase 1 and 2 trials for the treatment of hypertriglyceridemia, a common metabolic condition characterized by high levels of triglycerides in the blood stream.

The American Heart Association has estimated that one-third of the U.S. population has elevated levels of triglycerides.

 

CaPre’s concentrated omega-3s from krill oil are absorbed into the body more efficiently than those from fish oils, enhancing bioavailability and providing benefits to a patient’s total lipid profile. That means that CaPre® doesn’t just lower triglycerides; it also has shown in clinical trials to have beneficial effects on “good” and “bad” cholesterol levels that affect heart health.
 


Laval, Québec, CANADA, Sept. 14, 2016 Acasti Pharma (NASDAQ:ACST TSX-V:APO) today announced that its bridging study for novel drug candidate CaPre® (omega-3 phospholipid) has successfully met its objectives, supporting Acasti’s strategy to pursue the U.S. Food and Drug Administration’s (FDA) 505(b)(2) regulatory pathway for approval. Acasti is developing CaPre for the treatment of patients with severe hypertriglyceridemia, a metabolic condition that contributes to increased risk of cardiovascular disease and pancreatitis. The 505(b)(2) regulatory pathway allows Acasti to streamline the overall development program required to support a New Drug Application (NDA) by relying on the safety data of an approved drug. 



Laval, Québec, CANADA, October 26, 2016 — Acasti Pharma (NASDAQ:ACST TSX-V:APO) today announced that the United States Patent and Trademark Office issued Acasti a patent (U.S. patent no. 9,475,830) directed to a method of treating hypertriglyceridemia by the administration of a concentrated phospholipid composition. 
This newly issued patent expands Acasti’s intellectual property portfolio related to concentrated therapeutic phospholipid omega-3 compositions covering methods for treating or preventing diseases associated with or related to cardiovascular disease. 

 







  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ACST
Current Price
Volume:
Bid Ask Day's Range
SureTrader
ACST News: Report of Foreign Issuer (6-k) 12/05/2016 05:12:00 PM
ACST News: Report of Foreign Issuer (6-k) 11/28/2016 08:37:00 AM
ACST News: Report of Foreign Issuer (6-k) 11/03/2016 08:06:53 AM
ACST News: Report of Foreign Issuer (6-k) 10/26/2016 09:10:35 AM
ACST News: Report of Foreign Issuer (6-k) 10/11/2016 05:02:12 PM
News News Alert: Report of Foreign Issuer (6-k) 12/05/2016 05:12:00 PM
PostSubject
#265   * * $ACST Video Chart 11-29-16 * * ClayTrader 11/29/16 05:16:13 PM
#264   First good pick in a while of momentumotc newsletter GoodWill 11/29/16 09:50:24 AM
#263   Acasti Pharma Appoints Linda O’Keefe as Chief Financial Officer. I.B.Broke 11/28/16 06:18:54 PM
#262   “This patent furthers our strategy to build and I.B.Broke 10/26/16 10:50:59 PM
#261   Acasti Pharma Builds Intellectual Property Portfolio with Newly I.B.Broke 10/26/16 09:23:27 PM
#260   Volume in September of this year was caused I.B.Broke 10/24/16 04:55:20 PM
#259   Acasti Pharma Reports Second Quarter 2017 Financial Results I.B.Broke 10/11/16 08:25:03 PM
#258   "We think there’s a lot of potential here, ash111 10/06/16 01:37:34 PM
#256   large bids into close.light accumulation due to tiny float ash111 09/26/16 03:58:41 PM
#255   GSK is a $105B Co. Results from a ash111 09/16/16 04:11:11 PM
#254   15k in bids.nice volume.accumulation still going ash111 09/16/16 02:42:32 PM
#253   have noticed the potential too. ash111 09/15/16 04:32:50 PM
#252   One of few stocks I'm loading up on Chuck87 09/15/16 04:27:43 PM
#251   ACST 10.7m O/S, 5.2m float.that's very impressive: Acasti ash111 09/15/16 12:22:31 PM
#250   agree.cap is only $23m. ash111 09/15/16 10:01:16 AM
#249   Moving again this morning! Curt D 09/15/16 09:34:21 AM
#248   http://www.smart-publications.com/articles/pharmaceutical-sales-of-omega-3-fatty Chuck87 09/15/16 07:24:56 AM
#247   http://www.acastipharma.com/research-and-innovation/ Huge opportunity Will rep Chuck87 09/14/16 11:00:45 PM
#246   $ACST TA video Shortmetina 09/14/16 07:42:17 PM
#245   * * $ACST Video Chart 09-14-16 * * ClayTrader 09/14/16 04:53:58 PM
#244   Great results in a study. Beats out Lovaza Chuck87 09/14/16 04:45:58 PM
#243   Yep , I didn't pull the trigger at Kcricket 09/14/16 04:43:17 PM
#242   ACST another massive runner from open to close! cjstocksup 09/14/16 04:41:00 PM
#241   Lmao !!! Kcricket 09/14/16 03:09:27 PM
#240   A 6k lol PROPHETABLE 09/14/16 03:08:50 PM
#239   What's driving this rocket? Kcricket 09/14/16 03:04:34 PM
#238   Damn...sold too soon PROPHETABLE 09/14/16 03:00:37 PM
#237   * * $ACST Video Chart 12-16-15 * * ClayTrader 12/16/15 04:43:23 PM
#236   actually tommmorow - some sites had today but Buckey 10/14/15 05:19:55 PM
#235   10 to 1 RS effective October 14/2015 PJO 10/14/15 09:44:24 AM
#234   $ACST recent news/filings stocktrademan 07/19/15 10:17:26 AM
#233   Wow is right What snakes??? Board is dead Xrouter 05/01/15 09:03:06 PM
#231   Be very very careful here all. Snakes in Insidiou$ 05/01/15 02:48:36 PM
#230   See front loaded. Watch for the dump Insidiou$ 05/01/15 02:47:49 PM
#229   Scam alert. This stock was front loaded and Insidiou$ 05/01/15 02:46:50 PM
#228   Easy money pick! weeeeee Goldmind 05/01/15 01:28:52 PM
#227   Looking good Goldmind 05/01/15 12:35:40 PM
#226   news this morning. .627 on ask most of rivervalley 03/02/15 08:59:21 AM
#225   Severely. jcseattle 02/11/15 02:59:05 PM
#224   We need news dough_maker 02/09/15 02:54:04 PM
#223   I thought detailed results of their Phase II dough_maker 01/27/15 01:08:15 PM
#222   Looking good here! Shaka_Zulu 01/08/15 07:34:21 PM
#221   Much higher volume today than we have seen dough_maker 01/06/15 12:02:21 PM
#220   Came across this video from 2012. Very encouraging. dough_maker 01/06/15 12:47:45 AM
#219   Been stuck here since I thought $1 was Xrouter 12/21/14 07:39:50 AM
#218   Haha. I'm glad someone got it jcseattle 12/20/14 11:39:05 PM
#217   Nice call I think it will go up,if Xrouter 12/20/14 10:32:14 PM
#216   Gonna be a surprise. Good or bad but unexpected. jcseattle 12/20/14 06:03:33 PM
#215   News? Last Sept note ". Acasti PJO 12/18/14 02:57:25 PM
#214   Target .60 then .92 Shaka_Zulu 12/15/14 05:17:06 PM
PostSubject